Ticker: TCRX

TScan Therapeutics, Inc. (NYSE: TCRX) - Quick read on what's happening inside Short summary: the company is stepping up R&D and converting collaboration activity (Amgen) into recognitions of revenue while continuing to burn cash. Management says current resources fund operations into Q1 2027, but...